Pearls

Getting to the bottom of ‘refractory’ disorders

Author and Disclosure Information

 

References

When evaluating a patient diagnosed as having a “refractory” mental disorder, ask yourself:

  • Is the working diagnosis correct?
  • Could another undiagnosed condition be hindering response to treatment?
  • Is the patient adhering to his or her prescribed treatment?
  • Have prior medication trials used adequate dosages and durations?

For example, in a patient diagnosed with “refractory depression,” undiagnosed bipolar depression may explain the lack of response to antidepressant monotherapy. An undiagnosed general medical condition, such as hypothyroidism, would also explain the lack of response.

Also consider the effects of a comorbid psychiatric disorder. Anxiety, substance use, and personality disorders are common in patients with “refractory” depression.

Addressing nonadherence

Always suspect nonadherence—a frequent problem among patients with mental disorders—when assessing a “refractory” condition.1,2 Collateral sources of information such as family, friends, and previous inpatient and outpatient psychiatrists can help clarify this issue when the patient’s account seems unreliable.

If the patient is not adhering to prescribed medication, re-evaluate your therapeutic alliance by considering these questions:

  • Has the patient seemed comfortable and open during recent sessions?
  • Has he or she been able to discuss emotionally laden material that might lead to shame or guilt?
  • Did the patient maintain eye contact and respond appropriately to questions and observations?
If not, your alliance may lack the trust necessary for optimal treatment. To build trust with your patient, discuss your concerns about nonaherence in a warm and supportive manner. As you identify and emphatically address your patient’s concerns, he or she will likely become more engaged and more adherent with all aspects of treatment.

If the patient has been following the treatment plan but complains of persistent symptoms, verify that an adequate dosage (often the maximum recommended) and duration (at least 4 to 6 weeks for major depression) of medication have been prescribed. Also assess the adequacy of any psychotherapy.3

Recommended Reading

New-Onset Epilepsy Mimics Dementia in the Elderly
MDedge Psychiatry
Rivastigmine May Delay Dementia in Parkinson's
MDedge Psychiatry
Dual Abuse Concerns May Hinder Buprenorphine Tx
MDedge Psychiatry
Delayed Smoking Cessation Improved Alcohol Treatment
MDedge Psychiatry
Smoking Among Physicians Is at All-Time Low
MDedge Psychiatry
Organized Acute Stroke Care Flourishes in U.S. : American Stroke Association task force releases recommendations to implement stroke care systems.
MDedge Psychiatry
Pituitary Dysfunction May Occur After Brain Injury
MDedge Psychiatry
Attention Problems Common With Sleep Apnea and Insomnia in Adults
MDedge Psychiatry
Mutation Linked to Some Cases of Parkinson's : Identifying gene raises ethical questions about its use in testing, given the lack of preventive therapy.
MDedge Psychiatry
New Findings Improve Counseling for Epilepsy Surgery
MDedge Psychiatry